United Therapeutics (UTHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in ...

Leerink Partnrs dropped their FY2024 earnings per share estimates for shares of United Therapeutics in a research report ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

Equities research analysts at Leerink Partnrs dropped their Q4 2024 earnings per share estimates for United Therapeutics in a ...

In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against the other biotech stocks. The biotechnology sector is expanding quickly due to ...

Julie Hyman outlines the top stories on Wall Street in this Market Minute. Robinhood Markets (HOOD) stock rallies after reporting earnings driven by a surge in crypto trading. MGM Resorts ...

The U.S. Food and Drug Administration has cleared United Therapeutics (Nasdaq: UTHR) to begin a clinical trial that involves transplanting kidneys of gene-edited pigs into people with kidney failure.

BTIG analyst Julian Harrison maintained a Hold rating on United Therapeutics (UTHR – Research Report) on January 21. The company’s shares ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

United Therapeutics Corp. (UTHR), a public benefit corporation, announced Monday that the U.S. Food and Drug Administration (FDA) has ...